The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death
2021 · Cancer Science · 13 citations
https://doi.org/10.1111/cas.14885
K
Kaishi Satomi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
168
Papers
2.2K
Citations
24
h-index
45
i10-index
Kaishi Satomi is an academic researcher from National Cancer Center Hospital East. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Heat shock proteins research & Signaling Pathways in Disease. The author has an h-index of 24, co-authored 143 publications.
ORCID: 0000-0001-7611-5822Papers by this author
worksA case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement
2015 · Surgical Case Reports · 8 citations
https://doi.org/10.1186/s40792-015-0042-4
Clinical significance of tumor cell seeding associated with needle biopsy in patients with breast cancer
2023 · Asian Journal of Surgery · 7 citations
https://doi.org/10.1016/j.asjsur.2023.01.026
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis
2024 · Brain Tumor Pathology · 3 citations
https://doi.org/10.1007/s10014-024-00494-9
Epileptogenic glioma in a 4-year-old child: a case report
2010 · Brain Tumor Pathology · 0 citations
https://doi.org/10.1007/s10014-010-0274-8
Unusual S-100 and SOX10 immunoreactivity in a case of basal-HER2 metaplastic carcinoma of the breast: A potential diagnostic pitfall
2020 · Human Pathology Case Reports · 0 citations
https://doi.org/10.1016/j.ehpc.2020.200394
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat